The Impact of Obesity on the Cardiovascular System.

Csige I, Ujvárosy D, Szabó Z, Lőrincz I, Paragh G, Harangi M, Somodi S. · 2018

Read The Impact of Obesity on the Cardiovascular System. by Csige I, Ujvárosy D, Szabó Z, Lőrincz I, Paragh G, Harangi M, Somodi S. (2018) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6247580.txt.

Introduction

Csige and co-authors review how obesity affects the heart and blood vessels. Their review appeared in the Journal of Diabetes Research. Obesity raises risk both directly and through linked conditions. Those conditions include high blood pressure, diabetes, and sleep apnoea. Extra weight also reshapes the heart itself. Changes in heart structure and function can lead to heart failure.

Stretched heart tissue raises the chance of rhythm problems and sudden death. The review also covers the obesity paradox, where heavier patients sometimes fare better once heart disease is present. New imaging methods can catch early heart changes before symptoms start. Early care can then aim to prevent attacks and failure. The authors gather the mechanisms behind each link in one place.

Catalog record

CREATORCsige I, Ujvárosy D, Szabó Z, Lőrincz I, Paragh G, Harangi M, Somodi S.
YEAR2018
COLLECTIONPAPERS
FORMATTXT
FILE SIZE60 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC6247580

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

The Impact of Obesity on the Cardiovascular System By Imre Csige, Dóra Ujvárosy, Zoltán Szabó, István Lőrincz, György Paragh, Mariann Harangi, Sándor Somodi Published in: Journal of Diabetes Research DOI: 10.1155/2018/3407306 ABSTRACT Obesity is a growing health problem worldwide. It is associated with an increased cardiovascular risk on the one hand of obesity itself and on the other hand of associated medical conditions (hypertension, diabetes, insulin resistance, and sleep apnoea syndrome). Obesity has an important role in atherosclerosis and coronary artery disease. Obesity leads to structural and functional changes of the heart, which causes heart failure. The altered myocardial structure increases the risk of atrial fibrillation and sudden cardiac death. However, obesity also has a protective effect on the clinical outcome of underlying cardiovascular disease, the phenomenon called obesity paradox. The improved cardiac imaging techniques allow the early detection of altered structure and function of the heart in obese patients. In this review, we attempt to summarize the relationship between obesity and cardiovascular diseases and outline the underlying mechanisms. The demonstrated new techniques of cardiac diagnostic procedures allow for the early detection and treatment of subclinical medical conditions and, therefore, the prevention of cardiovascular events. 1. INTRODUCTION Obesity has been a health problem of growing significance all over the world; its prevalence is increasing in both developed and developing countries [1]. According to WHO data, 39% of the global population above 18 years of age are overweight and of these, 13% are obese. Numerous studies have demonstrated a relationship between obesity and cardiovascular diseases (stable coronary disease, acute myocardial infarction, heart failure, cardiac arrhythmias, and sudden cardiac death). The association between obesity and hypertension, diabetes mellitus, dyslipidaemias, and sleep apnoea syndrome has also been shown to increase the incidence of cardiovascular disorders [2]. Body mass index (BMI) is used for measuring the extent of obesity; however, it gives no information on fat distribution, which is of high significance in cardiovascular risk [3]. Therefore, novel clinical measurements (e.g., abdominal circumference and the calculation of waist/hip ratio) have been introduced with the aim of characterizing central or abdominal obesity. Abdominal circumference above 102 cm in the case of men and above 88 cm in the case of women qualifies as central obesity and involves increased cardiovascular risk [4]. A waist/hip ratio above 0.9 in the case of men and above 0.85 in the case of women indicates central obesity [5]. 2. THE RELATIONSHIP BETWEEN OBESITY AND ATHEROSCLEROSIS In the past three decades, many details of the pathophysiological processes of obesity and atherosclerosis have been revealed. Previously, both diseases had been regarded as lipid storage disorders with triglyceride accumulation in the fat tissue and cholesterol esters in atherosclerotic plaques. Nowadays, both obesity and atherosclerosis are considered chronic inflammatory conditions, in which the activation of both nonspecific and adaptive immune processes is assigned a significant role [6, 7]. The pathogenesis of obesity and atherosclerosis has several common factors. In both cases, lipids, oxidized LDL particles, and free fatty acids activate the inflammatory process and trigger the disease. Inflammation is responsible for all the steps towards atherosclerosis, from early endothelial dysfunction to the atherosclerotic plaques causing complications, and is related to obesity, insulin resistance, and type 2 diabetes. The fatty tissue releases adipocytokines, which induce insulin resistance, endothelial dysfunction, hypercoagulability, and systemic inflammation, thereby facilitating the atherosclerotic process. In visceral obesity, inflammatory adipocytokines (e.g., TNF-α, IL-6, MCP-1, leptin, and resistin) rise to higher levels. Moreover, the increased level of C-reactive protein is associated with an increased risk of myocardial infarction, peripheral vascular disease, and diabetes mellitus [8–10]. Interestingly, a clinical study performed on obese women confirmed that body weight reduction achieved through lifestyle changes reduces the level of inflammatory biomarkers and insulin resistance. In the course of the process, adiponectin, an anti-inflammatory and insulin-sensitizing adipocytokine, is released [11]. It is important to understand the relationship between the inflammatory process and atherosclerosis and the accelerating role of obesity. 3. OBESITY AND CORONARY ARTERY DISEASE Obesity is closely related to coronary atherosclerosis. A study performed on young patients showed that atherosclerosis begins several decades before manifested coronary artery disease. Atherosclerotic vascular lesions of patients with higher BMI values are more frequent and advanced compared to subjects with normal body weight [12]. According to longitudinal studies, at least two decades of obesity is likely to be an independent risk factor of coronary artery disease [13, 14]. A 10 kg rise in body weight increases the risk of coronary artery disease by 12% and at the same time, systolic blood pressure rises by 3 mmHg and diastolic by 2.3 mmHg as a consequence [15] (Figure 1). Furthermore, in the case of non-ST segment elevation myocardial infarction (NSTEMI) affecting young people, excess weight can be considered the most important risk factor, ahead of smoking. The higher the BMI, the sooner NSTEMI develops [16]. The same relationship can also be observed in the case of ST elevation myocardial infarction (STEMI) [17]. Based on the data available, obesity is an independent risk factor of STEMI developing at a young age [18] but at the same time excess weight can also be related to other vascular events. An increase in BMI by one unit causes a 4% rise in the risk of ischemic and a 6% rise in haemorrhagic strokes [19]. 4. OBESITY AND HEART FAILURE The frequency of heart failure is increasing; it is one of the major causes of death globally with a prevalence of approximately 3% in developed countries [20]. A close correlation can be observed between heart failure and obesity. According to data from the Framingham Heart Study, the rise of BMI by 1 kg/m2 increases the risk of heart failure by 5% in the case of men and 7% in the case of women [21]. Studies on heart failure show that 32%–49% of patients suffering from heart failure are obese and 31%–40% are overweight. In the case of obese and overweight patients, heart failure develops 10 years earlier than in the case of subjects with a normal BMI. The duration of morbid obesity is closely correlated to the development of heart failure: after 20 years of obesity, the prevalence of heart failure grows by 70% and after 30 years, the prevalence rises by 90% [22]. The significance of obesity is indicated by the fact that the Framingham Heart Study emphasized the pathogenic role of obesity for the development of heart failure in 11% of males and 14% of females [21]. The structural and functional changes of the heart observed in obesity alone contribute to a deterioration in myocardial function, which is often referred to as “obesity cardiomyopathy” [23]. Obesity leads to heart failure through several direct and indirect mechanisms. Excess weight leads to haemodynamic changes. A rise in both cardiac output and blood pressure has been observed; an increase in BMI of 5 kg/m2 involved a 5 mmHg rise in systolic blood pressure [24]. On one hand, it is related to the activation of the renin-angiotensin-aldosterone system and on the other hand, to the increased activity of the sympathetic nervous system [25, 26]. Obesity increases both the aldosterone level and the mineralocorticoid receptor expression, which promote interstitial cardiac fibrosis, platelet aggregation, and endothelial dysfunction. The above mechanisms explain

Read the complete text